possibly directors selling ord shares to pay for the options. at least this way they still get the capital raised.
ksx s/p will recover but price growth will depend on acceptable revenue growth . what that is depends on what the diluted market cap will be after the options are exercised.
personaly i see better value in medical device and service companies like som,cmp,avs,shc,vcr.
